S&P 500   3,241.59 (-2.35%)
DOW   26,846.88 (-2.93%)
QQQ   263.69 (-1.19%)
AAPL   106.84 (+0.00%)
MSFT   199.69 (-0.35%)
FB   247.04 (-2.17%)
GOOGL   1,425.13 (-1.79%)
AMZN   2,894.00 (-2.06%)
NVDA   491.05 (+0.71%)
TSLA   442.48 (+0.07%)
BABA   270.88 (-0.56%)
CGC   15.61 (-4.58%)
GE   6.24 (-9.30%)
MU   49.02 (-3.39%)
AMD   76.53 (+2.14%)
T   28.32 (-2.11%)
F   6.87 (-4.98%)
ACB   6.36 (-2.60%)
GILD   63.63 (-2.18%)
NFLX   479.17 (+1.96%)
DIS   124.40 (-3.29%)
BAC   24.11 (-4.36%)
BA   156.54 (-2.85%)
S&P 500   3,241.59 (-2.35%)
DOW   26,846.88 (-2.93%)
QQQ   263.69 (-1.19%)
AAPL   106.84 (+0.00%)
MSFT   199.69 (-0.35%)
FB   247.04 (-2.17%)
GOOGL   1,425.13 (-1.79%)
AMZN   2,894.00 (-2.06%)
NVDA   491.05 (+0.71%)
TSLA   442.48 (+0.07%)
BABA   270.88 (-0.56%)
CGC   15.61 (-4.58%)
GE   6.24 (-9.30%)
MU   49.02 (-3.39%)
AMD   76.53 (+2.14%)
T   28.32 (-2.11%)
F   6.87 (-4.98%)
ACB   6.36 (-2.60%)
GILD   63.63 (-2.18%)
NFLX   479.17 (+1.96%)
DIS   124.40 (-3.29%)
BAC   24.11 (-4.36%)
BA   156.54 (-2.85%)
S&P 500   3,241.59 (-2.35%)
DOW   26,846.88 (-2.93%)
QQQ   263.69 (-1.19%)
AAPL   106.84 (+0.00%)
MSFT   199.69 (-0.35%)
FB   247.04 (-2.17%)
GOOGL   1,425.13 (-1.79%)
AMZN   2,894.00 (-2.06%)
NVDA   491.05 (+0.71%)
TSLA   442.48 (+0.07%)
BABA   270.88 (-0.56%)
CGC   15.61 (-4.58%)
GE   6.24 (-9.30%)
MU   49.02 (-3.39%)
AMD   76.53 (+2.14%)
T   28.32 (-2.11%)
F   6.87 (-4.98%)
ACB   6.36 (-2.60%)
GILD   63.63 (-2.18%)
NFLX   479.17 (+1.96%)
DIS   124.40 (-3.29%)
BAC   24.11 (-4.36%)
BA   156.54 (-2.85%)
S&P 500   3,241.59 (-2.35%)
DOW   26,846.88 (-2.93%)
QQQ   263.69 (-1.19%)
AAPL   106.84 (+0.00%)
MSFT   199.69 (-0.35%)
FB   247.04 (-2.17%)
GOOGL   1,425.13 (-1.79%)
AMZN   2,894.00 (-2.06%)
NVDA   491.05 (+0.71%)
TSLA   442.48 (+0.07%)
BABA   270.88 (-0.56%)
CGC   15.61 (-4.58%)
GE   6.24 (-9.30%)
MU   49.02 (-3.39%)
AMD   76.53 (+2.14%)
T   28.32 (-2.11%)
F   6.87 (-4.98%)
ACB   6.36 (-2.60%)
GILD   63.63 (-2.18%)
NFLX   479.17 (+1.96%)
DIS   124.40 (-3.29%)
BAC   24.11 (-4.36%)
BA   156.54 (-2.85%)
Log in
CVE:MED

Medgold Resources Stock Forecast, Price & News

C$0.06
-0.01 (-7.69 %)
(As of 09/21/2020 12:36 PM ET)
Add
Compare
Today's Range
C$0.06
Now: C$0.06
C$0.06
50-Day Range
C$0.06
MA: C$0.06
C$0.08
52-Week Range
C$0.03
Now: C$0.06
C$0.11
Volume75,000 shs
Average Volume162,067 shs
Market CapitalizationC$8.09 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Medgold Resources Corp., an exploration stage company, engages in the acquisition and exploration of resource properties primarily in Serbia. It explores for gold, silver, and precious and base metals. The company holds 100% interest in the Tlamino project that comprises a block of two contiguous claims, including Donje Tlamino and Surlica-Ducat totaling 192 square kilometers; and five granted exploration licenses covering an area of approximately 570 square kilometers located in the Serbo-Macedonian Massif belt, Serbia. Medgold Resources Corp. is headquartered in Vancouver, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry Industrial Metals & Minerals
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+1-604-8015432

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowC$0.00 per share
Book ValueC$0.00 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$8.09 million
Next Earnings Date11/26/2020 (Estimated)
OptionableOptionable
C$0.06
-0.01 (-7.69 %)
(As of 09/21/2020 12:36 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MED News and Ratings via Email

Sign-up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Medgold Resources (CVE:MED) Frequently Asked Questions

How has Medgold Resources' stock price been impacted by Coronavirus (COVID-19)?

Medgold Resources' stock was trading at C$0.04 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MED stock has increased by 71.4% and is now trading at C$0.06.
View which stocks have been most impacted by COVID-19
.

When is Medgold Resources' next earnings date?

Medgold Resources is scheduled to release its next quarterly earnings announcement on Thursday, November 26th 2020.
View our earnings forecast for Medgold Resources
.

Who are some of Medgold Resources' key competitors?

What other stocks do shareholders of Medgold Resources own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medgold Resources investors own include Nevsun Resources (NSU) and Cannabis Technologies (IN).

Who are Medgold Resources' key executives?

Medgold Resources' management team includes the following people:
  • Mr. Simon T. P. Ridgway, Exec. Chairman (Age 70)
  • Mr. Kevin Bales, Chief Financial Officer (Age 52)
  • Mr. Jeremy Crozier, Pres, CEO & Director
  • Mr. Brent Cook BSc (Geology), Technical Advisor

What is Medgold Resources' stock symbol?

Medgold Resources trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MED."

How do I buy shares of Medgold Resources?

Shares of MED and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Medgold Resources' stock price today?

One share of MED stock can currently be purchased for approximately C$0.06.

How big of a company is Medgold Resources?

Medgold Resources has a market capitalization of C$8.09 million.

What is Medgold Resources' official website?

The official website for Medgold Resources is www.medgoldresources.com.

How can I contact Medgold Resources?

Medgold Resources' mailing address is 200 Burrard St Suite 650, VANCOUVER, BC V6C 3L6, Canada. The company can be reached via phone at +1-604-8015432.

This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.